Literature DB >> 11136652

Donepezil for Down's syndrome.

P S Kishnani, G A Spiridigliozzi, J H Heller, J A Sullivan, P M Doraiswamy, K R Krishnan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11136652     DOI： 10.1176/appi.ajp.158.1.143

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  3 in total

1.  Donepezil for the treatment of language deficits in adults with Down syndrome: a preliminary 24-week open trial.

Authors:  James H Heller; Gail A Spiridigliozzi; Jennifer A Sullivan; P Murali Doraiswamy; Ranga R Krishnan; Priya S Kishnani
Journal:  Am J Med Genet A       Date:  2003-01-15       Impact factor: 2.802

Review 2.  Basal Forebrain Cholinergic Neurons: Linking Down Syndrome and Alzheimer's Disease.

Authors:  Jose L Martinez; Matthew D Zammit; Nicole R West; Bradley T Christian; Anita Bhattacharyya
Journal:  Front Aging Neurosci       Date:  2021-07-12       Impact factor: 5.702

Review 3.  Donepezil for dementia in people with Down syndrome.

Authors:  Monica Mohan; Peter K Carpenter; Cathy Bennett
Journal:  Cochrane Database Syst Rev       Date:  2009-01-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.